{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:45:30Z","timestamp":1793389530865,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017245","name":"Hennepin Healthcare Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.cgh.2020.05.064","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T12:26:41Z","timestamp":1591705601000},"page":"580-589.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":543,"title":["Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9313-577X","authenticated-orcid":false,"given":"Zobair M.","family":"Younossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Stepanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janus","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Trimble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh","family":"AlQahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issah","family":"Younossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijaz","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Racila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2020.05.064_bib1","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2020.05.064_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2020.05.064_bib3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","article-title":"Epidemiology of chronic liver diseases in the USA in the past three decades","volume":"69","author":"Younossi","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2020.05.064_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaut.2015.08.021","article-title":"An update on liver transplantation: a critical review","volume":"66","author":"Neuberger","year":"2016","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cgh.2020.05.064_bib5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s41435-019-0066-z","article-title":"The remarkable history of the hepatitis C virus","volume":"20","author":"Pol","year":"2019","journal-title":"Genes Immun"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2020.05.064_bib6","first-page":"S8","article-title":"Introduction to hepatitis C virus infection: overview and history of hepatitis C virus therapies","volume":"22","author":"Puchades Renau","year":"2018","journal-title":"Hemodial Int"},{"key":"10.1016\/j.cgh.2020.05.064_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2020.05.064_bib8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/liv.13519","article-title":"In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered","volume":"38","author":"Younossi","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2020.05.064_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.29137","article-title":"Treatment of patients waitlisted for liver transplant with all-oral direct-acting antivirals is a cost-effective treatment strategy in the United States","volume":"66","author":"Ahmed","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2020.05.064_bib10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MCG.0000000000001172","article-title":"Among Medicare patients with hepatocellular carcinoma, non-alcoholic fatty liver disease is the most common etiology and cause of mortality","volume":"54","author":"Hester","year":"2019","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2020.05.064_bib11","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.05.064_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000358738","article-title":"Projections of trends in overweight in the elderly population in Germany until 2030 and international comparison","volume":"7","author":"Westphal","year":"2014","journal-title":"Obes Facts"},{"key":"10.1016\/j.cgh.2020.05.064_bib13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2013.08.011","article-title":"Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team","volume":"60","author":"Dyson","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2020.05.064_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039589","article-title":"High rates of obesity and non-communicable diseases predicted across Latin America","volume":"7","author":"Webber","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2020.05.064_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31173","article-title":"Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of nonalcoholic fatty liver disease","author":"Paik","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2020.05.064_bib16","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","article-title":"NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances","volume":"113","author":"Noureddin","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.05.064_bib17","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1007\/s10620-017-4684-x","article-title":"Liver transplantation for nonalcoholic steatohepatitis in the US: temporal trends and outcomes","volume":"62","author":"Cholankeril","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2020.05.064_bib18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.05.064_bib19","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/hep.30246","article-title":"Advancing age and comorbidity in a US insured population-based cohort of patients with chronic hepatitis B","volume":"69","author":"Nguyen","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2020.05.064_bib20","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s10620-018-5326-7","article-title":"Rising inpatient encounters and economic burden for patients with nonalcoholic fatty liver disease in the USA","volume":"64","author":"Nguyen","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2020.05.064_bib21","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1002\/cncr.31373","article-title":"Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: a real-world experience from 1998 to 2015","volume":"124","author":"Kim","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2020.05.064_bib22","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jamainternmed.2018.6536","article-title":"National trends and long-term outcomes of liver transplant for alcohol-associated liver disease in the United States","volume":"179","author":"Lee","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cgh.2020.05.064_bib24","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2105\/AJPH.2019.305002","article-title":"The depths of despair among US adults entering midlife","volume":"109","author":"Gaydosh","year":"2019","journal-title":"Am J Public Health"},{"key":"10.1016\/j.cgh.2020.05.064_bib25","article-title":"African Americans have a distinct clinical and histologic profile with lower prevalence of NASH and advanced fibrosis relative to Caucasians","author":"Satapathy","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.05.064_bib26","first-page":"41","article-title":"The epidemiology, risk profiling and diagnostic challenges of nonalcoholic fatty liver disease","volume":"6","author":"Iqbal","year":"2019","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.cgh.2020.05.064_bib27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2020.05.064_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173499","article-title":"Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States","volume":"12","author":"Le","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2020.05.064_bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hep4.1285","article-title":"Prevalence of nonalcoholic fatty liver disease in the female population","volume":"3","author":"Arshad","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cgh.2020.05.064_bib30","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/hep4.1419","article-title":"Mortality related to nonalcoholic fatty liver disease is increasing in the United States","volume":"3","author":"Paik","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cgh.2020.05.064_bib31","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/hep.26761","article-title":"Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2020.05.064_bib32","doi-asserted-by":"crossref","first-page":"e11518","DOI":"10.1097\/MD.0000000000011518","article-title":"Liver transplantation for cryptogenic cirrhosis (CC) and nonalcoholic steatohepatitis cirrhosis: data from the Scientific Registry of Transplant Recipients: 1994 to 2016","volume":"97","author":"Golabi","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cgh.2020.05.064_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ajg.2014.134","article-title":"Nonalcoholic fatty liver disease is underrecognized in the primary care setting","volume":"110","author":"Blais","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.05.064_bib34","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1007\/s10620-013-2740-8","article-title":"Identifying practice gaps to optimize medical care for patients with nonalcoholic fatty liver disease","volume":"58","author":"Wieland","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2020.05.064_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cld.2015.10.001","article-title":"Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world","volume":"20","author":"Sayiner","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cgh.2020.05.064_bib36","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.3748\/wjg.v23.i36.6571","article-title":"Nonalcoholic fatty liver disease: evolving paradigms","volume":"23","author":"Lonardo","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.05.064_bib37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12916-018-1103-x","article-title":"Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease","volume":"16","author":"Alexander","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.cgh.2020.05.064_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2020.05.064_bib39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/apt.15580","article-title":"The impact of modifiable risk factors on the long-term outcomes of non-alcoholic fatty liver disease","volume":"51","author":"Paik","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2020.05.064_bib40","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4254\/wjh.v9.i15.697","article-title":"Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: what we do, what we should do","volume":"9","author":"Sanchez-Torrijos","year":"2017","journal-title":"World J Hepatol"},{"key":"10.1016\/j.cgh.2020.05.064_bib41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/cld.721","article-title":"The association between nonalcoholic fatty liver disease and cardiovascular disease outcomes","volume":"12","author":"Wong","year":"2018","journal-title":"Clin Liver Dis (Hoboken)"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356520307758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356520307758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:33:08Z","timestamp":1761543188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356520307758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1542356520307758"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2020.05.064","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2020.05.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the AGA Institute","name":"copyright","label":"Copyright"}]}}